0001140361-18-018863.txt : 20180417 0001140361-18-018863.hdr.sgml : 20180417 20180417202259 ACCESSION NUMBER: 0001140361-18-018863 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180416 FILED AS OF DATE: 20180417 DATE AS OF CHANGE: 20180417 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Murray Mark J. CENTRAL INDEX KEY: 0001628383 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34949 FILM NUMBER: 18760095 MAIL ADDRESS: STREET 1: C/O ARBUTUS BIOPHARMA CORP. STREET 2: 100-8900 GLENLYON PARKWAY CITY: BURNABY STATE: A1 ZIP: V5J 5J8 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Arbutus Biopharma Corp CENTRAL INDEX KEY: 0001447028 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 980597776 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100-8900 GLENLYON PARKWAY CITY: BURNABY STATE: A1 ZIP: V5J 5J8 BUSINESS PHONE: 604-419-3200 MAIL ADDRESS: STREET 1: 100-8900 GLENLYON PARKWAY CITY: BURNABY STATE: A1 ZIP: V5J 5J8 FORMER COMPANY: FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS Corp DATE OF NAME CHANGE: 20110607 FORMER COMPANY: FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS CORP DATE OF NAME CHANGE: 20081003 4 1 doc1.xml FORM 4 X0306 4 2018-04-16 0 0001447028 Arbutus Biopharma Corp ABUS 0001628383 Murray Mark J. C/O ARBUTUS BIOPHARMA CORP. SUITE 100, 8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 BRITISH COLUMBIA, CANADA 1 1 0 0 President & CEO Common Shares 2018-04-17 4 M 0 27007 0.354 A 316396 D Employee Stock Option (Right to Buy) 5.20 2018-04-16 4 A 0 418187 0 A 2028-04-16 Common Stock 418187 418187 D Employee Stock Option (Right to Buy) 0.354 2018-04-17 4 M 0 27007 0 D 2008-03-30 2018-03-01 Common Stock 27007 0 D The options vest as follows: 1/3 on April 16, 2019; 1/3 on April 16, 2020; and 1/3 on April 16, 2021. Converted from Canadian exercise price of $0.4444; Cdn$1.2552=US$1.00. Expiration date extended through termination of blackout period. /s/ Mark J. Murray 2018-04-17